Skip to main content

Advertisement

SpringerLink
Log in

Prebiotics: future trends in health care

  • Review
  • Published:
Mediterranean Journal of Nutrition and Metabolism

Abstract

Prebiotics are the non-digestible food ingredients, which help in the successful digestion of the food components in the gut and lower intestine. They play an important role in the promotion of the growth of “good” bacteria in the intestine and gut of humans. In other words, nutraceuticals are beneficial for the maintenance of gut microbiota, microflora, and human health. This study specially reviewed different articles on the role of prebiotics in hepatic encephalopathy, cardiovascular diseases, constipation, diarrhea, hypotriglyceridemia, and type 2 diabetes. In conclusion, prebiotics are supplements to improve health and can favorably treat biological disorders.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bronzwaer S (2008) EFSA scientific forum “from safe food to healthy diets”. EU risk assessment—past present and future. Trends Food Sci Technol 19:S2–S8

    Article  CAS  Google Scholar 

  2. Roberts SB, Rosenberg I (2006) Nutrition and aging: changes in the regulation of energy metabolism with aging. Physiol Rev 86:651–667

    Article  CAS  Google Scholar 

  3. Perez-Cueto FJ, Verbeke W, de Barcellos MD, Grunert KG et al (2009) Food-related lifestyles and their association to obesity in five European countries. Appetite 54:156–562

    Article  Google Scholar 

  4. Gilbert RL, Mielke JH (eds) (1985) The analysis of prehistoric diets. Academic Press, Orlando, pp 622

  5. Eaton SB, Eaton SB III, Konner MJ, Shostak M (1996) An evolutionary perspective enhances understanding of human nutritional requirements. J Nutr 126:1732–1740

    Google Scholar 

  6. Eaton SB, Eaton SB III, Konner MJ (1997) Paleolithic nutrition revisited: a twelve-year retrospective on its nature and implications. Eur J Clin Nutr 51:207–216

    Google Scholar 

  7. Roskam AJ, Kunst AE, Van Oyen H et al (2009) Comparative appraisal of educational inequalities in overweight and obesity among adults in 19 European countries. Int J Epidemiol (Epub ahead of print)

  8. Crawford MA, Marsh D (1995) Nutrition and evolution. Keats Publishing, New Canaan

    Google Scholar 

  9. Bland JS (1996) Phytonutrition, phytotherapy, and phytopharmacology. Altern Ther Health Med 2:73–76

    CAS  Google Scholar 

  10. Berger MM, Shenkin A (2006) Vitamins and trace elements: practical aspects of supplementation. Nutrition 22:952–955

    Article  CAS  Google Scholar 

  11. Bagchi D (2006) Nutraceuticals and functional foods regulations in the United States and around the world. Toxicol 221:1–3

    Article  CAS  Google Scholar 

  12. Ramaa CS, Shirode AR, Mundada AS, Kadam VJ (2006) Nutraceuticals—an emerging era in the treatment and prevention of cardiovascular diseases. Curr Pharm Biotechnol 7:15–23

    Article  CAS  Google Scholar 

  13. Brower V (1998) Nutraceuticals: poised for a healthy slice of the healthcare market? Nat Biotechnol 16:728–731

    Article  CAS  Google Scholar 

  14. Zeisel SH (1999) Regulation of “Nutraceuticals”. Science 285:185–186

    Article  Google Scholar 

  15. Whitman M (2001) Understanding the perceived need for complementary and alternative nutraceuticals: lifestyle issues. Clin J Oncol Nurs 5:190–194

    CAS  Google Scholar 

  16. Koletzko B, Aggett PJ, Bindels JG et al (1998) Growth, development and differentiation: a functional food science approach. Br J Nutr 80(Suppl):5–45

    Article  Google Scholar 

  17. Halsted CH (2003) Dietary supplements and functional foods: 2 sides of a coin? Am J Clin Nutr 77:1001S–1007S

    CAS  Google Scholar 

  18. FDA/CFSAN resources page. Food and Drug Administration Web site. Dietary Supplement Health and Education Act of 1994. Available at: http://vm.cfsan.fda.gov/dietsupp.html

  19. DeFelice SL (2002) FIM Rationale and Proposed Guidelines for the Nutraceutical Research & Education Act (NREA), November 10. Foundation for Innovation in Medicine. Available at: http://www.fimdefelice.org/archives/arc.researchact.html

  20. Ross S (2000) Functional foods: the Food and Drug Administration perspective. Am J Clin Nutr (Suppl) 71:1735–1738

    Google Scholar 

  21. Iriti M, Vitatini S, Fico G et al (2010) Neureoprotective herbs and foods from different traditional medicines and diets. Molecules 15:3517–3555

    Article  CAS  Google Scholar 

  22. Gidley MJ (2004) Naturally functional foods—challenges and opportunities. Asia Pac J Clin Nutr 13(Suppl):31

    Google Scholar 

  23. Kalra EK (2003) Nutraceuticals—definition introduction. AAPS Pharm Sci 5:2–3

    Article  Google Scholar 

  24. Food and Agriculture Organisation of the United States (FAO). Report on Functional Foods, Food Quality and Standard Service (AGNS), 2007. Available online: http://www.fao.org/ag/agn/agns/files/Functional_Foods_Report_Nov2007.pdf (accessed on February 2010)

  25. FDA/CFSAN resources page. Food and Drug Administration. Dietary Supplement Health and Education Act of 1994. Available from: http://www.consumermanitoba.ca/resources.html

  26. Shahidi F, Naczk M (2004) Phenolics in food and nutraceuticals. CRC Press, Boca Raton

    Google Scholar 

  27. Kalra EK (2003) Nutraceuticals—definition and introduction. AAPS Pharm Sci 5:25. Available online: http://www.aapsj.org/view.asp. (accessed on 25 February 2010)

  28. De Vrese M, Schrezenmeir J (2008) Probiotics, prebiotics, and synbiotics. Adv Biochem Eng Biotechnol 111:1–66

    Google Scholar 

  29. Douglas LC, Sanders ME (2008) Probiotics and prebiotics in dietetics practice. J Am Diet Assoc 108:510–552

    Article  Google Scholar 

  30. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microflora: introducing the concept of prebiotics. J Nutr 125:1401–1412

    CAS  Google Scholar 

  31. Bellisle F, Diplock AT, Hornstra G et al (1998) Functional food science in Europe. Br J Nutr 80(Suppl):S3–S4

    Google Scholar 

  32. Clydesdale F (1997) A proposal for the establishment of scientific criteria for health claims for functional foods. Nutr Rev 55:413–422

    Article  CAS  Google Scholar 

  33. Roberfroid MB (2000) Concepts and strategy of functional food science: the European perspective. Am J Clin Nutr 71(Suppl):1660S–1664S

    CAS  Google Scholar 

  34. Roberfroid MB (1996) Functional effects of food components and the gastrointestinal system: chicory fructooligosaccharides. Nutr Rev 54:S38–S42

    Article  CAS  Google Scholar 

  35. Hoebregs H (1997) Fructans in foods and food products, ion-exchange chromatographic method: collaborative study. J Assoc Off Anal Chem Int 80:1029–1037

    CAS  Google Scholar 

  36. Van Loo J, Coussement P, De Leenheer L et al (1995) On the presence of inulin and oligofructose as natural ingredients in the western diet. Crit Rev Food Sci Nutr 35:525–552

    Article  Google Scholar 

  37. Cummings JH, Roberfroid MB (1997) A new look at dietary carbohydrate: chemistry, physiology and health. Eur J Clin Nutr 51:417–442

    Article  CAS  Google Scholar 

  38. Blaut M (2002) Relationship of prebiotics and food to intestinal microflora—an introduction. Eur J Nutr 41. doi:10.1007/s00394-002-1102-7

  39. Drasar BS, Roberts AK (1990) Control of the large bowel microflora. In: Hill MJ, Marsh PD (eds) Human microbial ecology. CRC Press, Boca Raton, pp 87–111

    Google Scholar 

  40. Park SF, Kroll RG (1993) Expression of listeriolysin and phosphatidylinositol-specific phopholipase C is repressed by the plant derived molecule cellebiose Listeria monocytogenes. Mol Microbiol 86:53–61

    Google Scholar 

  41. Tannock GW (2002) Probiotics and prebiotics: where we are going? In: Tannock GW (ed) Probiotics and prebiotics: where we are going? Caister Academic Press, Wymondham, pp 1–20

  42. Roberfroid MB (2000) Prebiotics and probiotics: are they functional foods? Am J Clin Nutr 71:1682S–1687S

    CAS  Google Scholar 

  43. Scholz-Arhens KE, Schaafsma G, Schrezenmeir J et al (2001) Effects of prebiotics on mineral metabolism. Am. J Clin Nutr 73:2(Suppl4):59S–64S

    Google Scholar 

  44. Scholz Ahrens KE, Schrezenmeir J (2002) Inulin, oligofructose and mineral metabolism-experimental data and mechanism. Br J Nutr, 87(Suppl2):S179–S186

    Google Scholar 

  45. Coudary C, Demigne C, Rayssiguier Y (2003) Effects of dietary fibres on magnmesium absorption in animals and humans. J Nutr 133:1–4

    Google Scholar 

  46. Cashman K (2003) Prebiotics and calcium bioavailability. Curr Issues Intest Microbiol 4:21–32

    CAS  Google Scholar 

  47. Reddy BS, Rivenson A (1993) Inhibitory effect of Bifidobacterium longum on colon, mammary and liver carcinogenesis induced by 2-amino-3 methylimidazol[4, 5-f]quinoline, a food mutagen. Cancer Res 53:3914–3918

    CAS  Google Scholar 

  48. Fiordaliso M, Kok N, Desager JP et al (1995) Dietary oligofructose lowers triglycerides, phospholipids and cholesterol in serum and very low density lipoproteins of rats. Lipids 30:163–167

    Article  CAS  Google Scholar 

  49. Takase S, Goda T, Watanabe M (1994) Mono stearyl glycerol-starch complex: its digestibility and effects on glycemic and lipogenic responses. J Nutr 40:23–36

    CAS  Google Scholar 

  50. Davidson MH, Maki KC, Synecki C et al (1998) Evaluation of the influence of dietary inulin on serum lipids in adults with hypercholesterolemia. Nutrition 18:503–517

    CAS  Google Scholar 

  51. Reddy DS, Hamid R, Rao CV (1997) Effect of dietary oligofructose and inulin on colonic preneoplastic aberrant crypt foci inhibition. Carcinogenesis 18:1371–1374

    Article  CAS  Google Scholar 

  52. Rowland IR, Rumney CJ, Coutts JT, Lievense LC (1997) Effect of Bifidobacterium longum and inulin on gut bacterial metabolism and carcinogen-induced crypt foci in rats. Carcinogenesis 19:281–285

    Article  Google Scholar 

  53. Burr ML, Butland BK, King S, Vaughan Williams E (1989) Changes in asthma prevalence: two surveys 15 years. Arch Dis Child 64:1452–1456

    Article  CAS  Google Scholar 

  54. Halken S (2004) Prevention of allergic disease in childhood and epidermiological aspects of primary and secondary allergy prevention. Pediatr Allergy Immunol 15(Suppl 16):4–5

    Google Scholar 

  55. Presscott HM, Apajalahati JH, Rautonen N, Stowell J et al (2004) Polydextrose, lactitol and fructo oligosaccharides fermentation by colonic bacteria in a three stage continuous culture system. Appl Environ Microbiol 70:4505–4511

    Article  Google Scholar 

  56. Schultz Larsen F (1996) Atopic dermatitis: an increasing problem. Pediatr Allergy Immunol 7:51–53

    Article  CAS  Google Scholar 

  57. Holt PG, Sly PD, Bjorksten B (1997) Atopic versus infectious diseases in childhood: a question of balance? Pediatr Allergy Immunol 8:53–58

    Article  CAS  Google Scholar 

  58. Blaut M (2002) Eur J Nutr 41(Suppl1):111–116

    Google Scholar 

  59. Gasbarrini G, Montaltoa M, Assisi R (1999) The role of bacterial flora and its products in the functioning of the small Intestine Digestive and Liver Disease Supplements 1 (translation). Ital J Gastroenterol Hepatol 31:481–488

    CAS  Google Scholar 

  60. Kleessen B, Blaut M (2005) Modulation of gut mucosal biofilms. Br J Nutr 93(Suppl 1):S35–S40

    Article  CAS  Google Scholar 

  61. Roberfroid MB (2007) Prebiotics: the concept revisited. J Nutr 137:830S–837S

    CAS  Google Scholar 

  62. Haarman M, Knol J (2005) Quantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formula. Appl Environ Microbiol 71:2318–2324

    Article  CAS  Google Scholar 

  63. Scholtens PA, Alles MS, Bindels JG, Knol J et al (2006) Bifidogenic effects of solid weaning foods with added prebiotic oligosaccharides: a randomised controlled clinical trial. J Pediatr Gastroenterol Nutr 42:553–559

    Article  CAS  Google Scholar 

  64. Shoaf K, Mulvey GL, Armstrong GD, Hutkins RW (2006) Prebiotics galactooligosaccharides reduce adherence of enteropathogenic Escherichia coli to tissue culture cells. Infect Immun 74:6920–6928

    Article  CAS  Google Scholar 

  65. Gibson GR, Wills CL, Van Loo J (1994) Non-digestible oligosaccharides and bifidobacteria implication for health. Int Sugar J 96:381–387

    CAS  Google Scholar 

  66. Arjan PV, Jan K, Bernd S et al (2010) Specific prebiotic oligosaccharides modulate the early phase of a murine vaccination response. Int Immunopharmacol 10:619–625

    Article  Google Scholar 

  67. Mizota T (1996) Functional and nutritional foods containing bifidogenic factors. Bull Int Dairy Found 313:31–35

    CAS  Google Scholar 

  68. Gibson GR, Wang X (1994) Regulatory effect of bifidobacteria on the growth of other colonic bacteria. J Appl Bacteriol 77:412–420

    Article  CAS  Google Scholar 

  69. Kleessen B, Hartman L, Blaut M (2001) Oligofructose and long chain inulin influence the gut microbial ecology of rats associated with a human faecal flora. Br J Nutr 86:291–300

    Article  CAS  Google Scholar 

  70. Watzl B, Girrbach S, Roller M (2005) Inulin, oligofructose and immunomodulation. Br J Nutr 93:S49–S55

    Article  CAS  Google Scholar 

  71. Videla S, Vilaseca J, Antolin M et al (2001) Dietary inulin improves distal colitis induced by dextran sodium sulfate in the rat. Am J Gastroenterol 96:1486–1493

    Article  CAS  Google Scholar 

  72. Welters CF, Heineman E, Thunnissen FB et al (2002) Effect of dietary inulin supplementation on inflammation of pouch mucosa in patients with an ileal pouch-anal anastomosis. Dis Colon Rectum 45:621–627

    Article  Google Scholar 

  73. Hoentjen F, Welling G, Harmsen H et al (2005) Reduction of colitis in HLA-B27 transgenic rats is associated with microflora changes and immunomodulation. Inflamm Bowel Dis 11:977–985

    Article  Google Scholar 

  74. Lindsay JO, Whelan K, Stragg AJ et al (2006) Clinical, microbiological, and immunological effects of fructo-oligosaccharide in patients with Crohn’s disease. Gut 55:348–355

    Article  CAS  Google Scholar 

  75. Leenen CHM, Dieleman L (2007) Inulin and oligofructose in chronic inflammatory bowel disease. J Nutr 137:2572S–2575S

    CAS  Google Scholar 

  76. Burns AJ, Rowland IR (2000) Anti carcinogenicity of prebiotics and probiotics. Curr Issues Intest Microbiol 1:13–24

    CAS  Google Scholar 

  77. Gallahar DD, Khil J (1999) The effect of synbiotics on colon carcinogenesis in rats. J Nutr 129:1483S–1487S

    Google Scholar 

  78. Reddy BS (1999) Possible mechanisms by which pro and prebiotics influence colon carcinogenesis and tumor growth. J Nutr 129:1478S–1482S

    CAS  Google Scholar 

  79. Blei A, Cordoba J (2001) Hepatic encephalopathy. Am J Gastroenterol 96:1968–1976

    Article  CAS  Google Scholar 

  80. Groenweg M, Quero JC, De Bruijn I et al (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28:45–49

    Article  Google Scholar 

  81. Weissenborn K, Ennen JC, Schomerus H, Ruckery N, Hecker H (2001) Neuropsychological characterization of hepatic encephalopathy. J Hepatol 34:768–773

    Article  CAS  Google Scholar 

  82. Solga SF (2001) Probiotics can treat hepatic encephalopathy. Med Hypotheses 61:307–313

    Article  Google Scholar 

  83. Vogels GD, Van der Drift C (1977) Degradation of purines and pyrimidines. Bacteriol Rev 40:403–468

    Google Scholar 

  84. Bongaerts GPA, Vogels GD (1976) Uric acid degradation by Bacillus fastidiosus strains. J Bacteriol 125:689–697

    CAS  Google Scholar 

  85. Cherbut C (2003) Motor effects of short-chain fatty acids and lactate in the gastrointestinal tract. Proc Nutr Soc 62:95–99

    Article  CAS  Google Scholar 

  86. Bongaerts G, Severijnen R, Timmerman H (2005) Effects of antibiotics, probiotics and prebiotics in the treatment of hepatic encephalopathy. Med Hypotrheses 64:64–68

    Article  CAS  Google Scholar 

  87. Marcil V, Delvin E, Garofalo C, Levy E (2003) Butyrate impairs lipid transport by inhibiting microsomal triglyceride transfer protein in Caco-2 cells. J Nutr 133:2180–2183

    CAS  Google Scholar 

  88. Borthakur A, Saksena S, Gill RK et al (2008) Regulation of monocarboxylate transporter 1 (MCT1) promoter by butyrate in human intestinal epithelial cells: involvement of NF-kappa pathway. J Cell Biochem 103:1452–1463

    Article  CAS  Google Scholar 

  89. Bruzzese E, Volpicelli M, Squaglia M, Tartaglione A et al (2006) Impact of prebiotics on human health digestive and liver disease 38(Suppl):S283–S287

    Article  Google Scholar 

  90. Roberfroid MB (2005) Introducing inulin-type fructans. Br J Nutr 93:S13–S25

    Article  CAS  Google Scholar 

  91. Napolitano A, Costabile A, Martin-Pelaez S et al (2009) Potential prebiotics activity of oligosaccharides obtained by enzymatic conversion of durum wheat insoluble dietary fibre into soluble dietary fiber. Nutr Metab Cardiovasc Dis 19:283–290

    Google Scholar 

  92. Howard MD, Gordon DT, Garleb KA, Kerley MS (1995) Dietary fructooligosaccharide, xylooligosaccharide and gum arabic have variable effects on cecal and colonic microbiota and epithelial cell proliferation in mice and rats. J Nutr 125:2604–2609

    CAS  Google Scholar 

  93. Roberfroid MB, Van Loo JAE, Gibson GR (1998) The bifidogenic nature of chicory inulin and its hydrolysis products. J Nutr 128:11–19

    CAS  Google Scholar 

  94. Levrat MA, Rémésy C, Demigné C (1991) High propionic-acid fermentations and mineral accumulation in the cecum of rats adapted to different levels of inulin. J Nutr 121:1730–1737

    CAS  Google Scholar 

  95. Napolitano A, Costabile A, Martin-Pelaez S et al (2009) Potential prebiotic activity of oligosaccharides obtained by enzymatic conversion of durum wheat insoluble dietary fibre into soluble dietary fibre. Nutr Metab Cardiovasc Dis 19:283–290

    Article  CAS  Google Scholar 

  96. Durmic Z, Pethic DW, Pluske JR, Hampson DJ (1998) Changes in bacterial populations in the colon of pigs fed different sources of dietary fibre, and the development of swine dysentery after experimental infection. J Appl Microbiol 85:574–582

    Article  CAS  Google Scholar 

  97. Gómez-Conde MS, Garcia J, Chamorro S, Eiras P et al (2007) Neutral detergent-soluble fiber improves gut barrier function in twenty five-day-old weaned rabbits. J Anim Sci 85:3313–3321

    Article  Google Scholar 

  98. Coppa GV, Zampini L, Galeazzi T, Gabrielli O (2006) Prebiotics in human milk: a review digestive and liver disease 38(Suppl):S291–S294

    Article  Google Scholar 

  99. Gibson GR, Roberfroid MB (1995) Dietary modulation of the human colonic microbiota—introducing the concept of prebiotics. J Nutr 125(6):1401–1412

    CAS  Google Scholar 

  100. De Souza VMC, Santos SF, Sgarbieri C (2011) The importance of prebiotics in functional foods and clinical practice. Food Nutr Sci 2:133–144

    Google Scholar 

  101. Carabin IG, Flamm WG (1999) Evaluation of safety of inulin and oligofructoseas. Dietary fibre. Regul Toxicol Pharmacol 30(3):268–282

    Article  CAS  Google Scholar 

  102. Modler HW (1994) Bifidogenic factors—sources, metabolism and applications. Int Dairy J 4(5):383–407

    Article  Google Scholar 

  103. Chung Y, Hsu C, Ko C, Chan Y (2007) Dietary Intake of Xylooligosaccharides improves the intestinal microbiota, Feed moisture and pH value in the elderly. Nutr Res 27(12):756–761

    Google Scholar 

  104. Nagendra R, Vishwanathan S, KumarS A, MurthyB K, Rao SV (1995) Effects of feeding milk formula containing lactulose to infants on fecal bifidobacterialflora. Nutr Res 15(1):15–24

    Article  Google Scholar 

  105. Passos LML, Park YK (2003) Fructooligosaccharides: implications in human health being and use in foods. Ciencia Rural 33(2):385–390

    Article  Google Scholar 

  106. Tuohy KM, Rouzaud GCM, Bruck WM, Gibson GR (2005) Modulation of the human gut microflora towards improved health using prebiotics—assessment of efficacy. Curr Pharm Des 11(1):75–90

    Article  CAS  Google Scholar 

  107. Tahiri M, Tressol JC, Arnaud J et al (2001) Five-week intake of short-chain fructooligosaccharides increases intestinal absorption and status of magnesium in postmenopausal women. J Bone Miner Res 16:2152–2160

    Article  CAS  Google Scholar 

  108. Boehm G. Stahl B, Oligosaccharides (2003) In: Mttila-Sandhlm T (ed) Functional dairy products. Woodhead Publ., Cambridge, pp 203–243

  109. Moro G, Minoli I, Mosca M et al (2002) Dosage related bifidogenic effects lof galactooligosaccharides and fructo oligosaccharides in formula fed ferm infants. J Pediatr Gastroenterol Nutr 34:291–295

    Article  CAS  Google Scholar 

  110. Jie Z, Bang-Yao L, Ming-Jie X, Hai-Wei L, Zu-Kang Z, Ting-Song W et al (2000) Studies on then Effects of polydextrose intake on physiologic functions in Chinese people. Am J Clin Nutr 72(6):1503–1509

    Google Scholar 

  111. H. Tomomatsu (1994) Health effects of oligosaccharides. Food Technol 48(10):61–65

    Google Scholar 

  112. Englyst HN, Cummings JH (1987) Digestion of polysaccharides of potato in the small intestine of man. Am J Clin Nutr 45:423–431

    CAS  Google Scholar 

  113. Griffin IJ, Davila PM, Abrams SA (2002) Non-digestible oligosaccharides and calcium absorption in girls with adequate calcium intakes. Br J Nutr 87(Suppl 2):S187–S191

    Article  CAS  Google Scholar 

  114. Abrams SA, Griffin IJ, Hawthorne KM (2005) A combination of prebiotic short- and long-chain inulin-type fructans enhances calcium absorption and bone mineralization in young adolescents. Am J Clin Nutr 82:471–476

    CAS  Google Scholar 

  115. Van den Heuvel EG, Muijs T, Van Dokkum W, Schaafsma G (1999) Lactulose stimulates calcium absorption in postmenopausal women. J Bone Miner Res 14:1211–1216

    Article  Google Scholar 

  116. Tateyama I, Hashii K, Johno I (2005) Effect of xylooligosaccharide intake on severe constipation in pregnant women. J Nutr Sci Vitaminol 51:445–448

    Article  CAS  Google Scholar 

  117. Livesey G (2003) Health potential of polyol as sugar replacers, with emphasis on low glycaemic properties. Nutr Res Rev 16:163–191

    Article  CAS  Google Scholar 

Download references

Acknowledgments

Authors are highly thanks full to Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology for providing necessary guidance and facilities. Authors would like to thanks NISCAIR (National Library) New Delhi for providing library facilities.

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of Pharmaceutical Technology, Meerut Institute of Engineering and Technology, Bypass Road, Baghpat Crossing, Meerut, 250005, Uttar Pradesh, India

    Rupali Singh, Pramod Kumar Sharma & Rishabha Malviya

Authors
  1. Rupali Singh
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Pramod Kumar Sharma
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Rishabha Malviya
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rupali Singh.

About this article

Cite this article

Singh, R., Sharma, P.K. & Malviya, R. Prebiotics: future trends in health care. Mediterr J Nutr Metab 5, 81–90 (2012). https://doi.org/10.1007/s12349-011-0065-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12349-011-0065-8

Keywords

Search

Navigation